Opioid pharmacotherapy in terminal disease

scientific article published in March 2004

Opioid pharmacotherapy in terminal disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1533-2500.2004.04004.X
P698PubMed publication ID17129300

P2093author name stringKenneth C Jackson
Brad Stanford
P2860cites workNormorphine, a neurotoxic metabolite?Q28334147
A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioidsQ33183931
Breakthrough pain: definition, prevalence and characteristicsQ33435886
Opioid rotation for cancer pain: rationale and clinical aspectsQ33765787
Opioid pseudoaddiction--an iatrogenic syndromeQ34523192
Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteersQ39442833
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidenceQ40485751
Practical use of rectal medications in palliative careQ41232201
Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonistsQ42281313
Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four casesQ44353030
Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients.Q51575955
EditorialQ56990784
Windup and central sensitization are not equivalentQ71705072
Management of cancer painQ77769507
P433issue1
P921main subjectpharmacotherapyQ701216
P304page(s)30-38
P577publication date2004-03-01
P1433published inPain PracticeQ2183039
P1476titleOpioid pharmacotherapy in terminal disease
P478volume4